Literature DB >> 2530424

Rate-control drug delivery systems: controlled release vs. sustained release.

Y W Chien1.   

Abstract

Recently, several technical advancements have been made in the development of new generation of drug delivery systems. These systems are capable of controlling the rate of drug delivery, sustaining the duration of therapeutic efficacy, and/or targeting the delivery of drug to a tissue. Depending upon the technical sophistication, these rate-control drug delivery systems can be classified into three major categories: (i) pre-programmed drug delivery, (ii) activation-controlled drug delivery, and (iii) feedback-regulated drug delivery. Various types of drug delivery devices which have been recently marketed or under active development are grouped, on technology basis, under each category. The fundamentals behind the development of each type of the rate-control drug delivery systems with the successful examples of biomedical application are analyzed, aiming to gain a better understanding of the science and technology involved as well as to pave a solid foundation for future development of innovative new drug delivery systems.

Mesh:

Substances:

Year:  1989        PMID: 2530424

Source DB:  PubMed          Journal:  Med Prog Technol        ISSN: 0047-6552


  4 in total

Review 1.  Current status of sustained release formulations in the treatment of hypertension. An overview.

Authors:  E Mutschler; H Knauf
Journal:  Clin Pharmacokinet       Date:  1999       Impact factor: 6.447

Review 2.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Studies in formulation and pharmacotechnical evaluation of controlled release transdermal delivery system of bupropion.

Authors:  Deepak Gondaliya; Kilambi Pundarikakshudu
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

4.  Preparation and pharmacokinetics in beagle dogs of ganershu sustained-release pellets.

Authors:  Jin-Huo Pan; Jian-Chun Wang; Zhi-Tao Jiang; Ting Zhang; Shao-Bo Ge; Ye-Xia Zhang; Xin Jin; Guo-Jun Yan
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.